Crestmont Private Wealth’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Buy
5,324
+51
+1% +$11.4K 0.36% 18
2025
Q4
$903K Sell
5,273
-396
-7% -$61.6K 0.29% 24
2025
Q3
$759K Buy
5,669
+622
+12% +$65.9K 0.25% 34
2025
Q2
$491K Buy
5,047
+298
+6% +$23.6K 0.18% 45
2025
Q1
$345K Buy
4,749
+1,435
+43% +$113K 0.15% 48
2024
Q4
$239K Buy
3,314
+634
+24% +$48.1K 0.11% 63
2024
Q3
$219K Buy
2,680
+450
+20% +$39.1K 0.1% 93
2024
Q2
$237K Buy
+2,230
New +$214K 0.11% 70

Other funds holding LRCX

Crestmont Private Wealth's LRCX Position: Q1 2026 in Review

Crestmont Private Wealth increased its Lam Research (LRCX) stake by 0.97% in Q1 2026, buying an estimated $11.4K and bringing the position to 5,324 shares worth $1.14M. The position accounts for 0.36% of the portfolio, ranked #18.

Crestmont Private Wealth first reported a position in LRCX in Q2 2024 and has held it in 8 quarters since. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Crestmont Private Wealth held 5,324 shares of Lam Research worth $1.14M as of Q1 2026.
  • Crestmont Private Wealth bought 51 Lam Research shares in Q1 2026, an estimated $11.4K.
  • Lam Research made up 0.36% of Crestmont Private Wealth's portfolio in Q1 2026, its #18 holding.
  • Crestmont Private Wealth first reported a position in Lam Research in Q2 2024 and has held it in 8 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Crestmont Private Wealth's 13F filing for Q1 2026, filed 8 May 2026.